🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Meningeal Neoplasms

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis NCT06933199NA4 sites📍 Ostrava📍 Brno📍 Hradec Králové University Hospital Ostrava · Tests: Neoadjuvant Stereotactic Radiotherapy (NaSRT), Postoperative Stereotactic Radiotherapy (SRT) 3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features NCT06955208NA1 site📍 Shenyang Shengjing Hospital · Tests: Magnetic Resonance Elastography, Intraoperative Assessment and Recording RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma NCT07150806Phase 1, Phase 21 site📍 Columbus Joshua Palmer · Tests: Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography, Echocardiography Test, Gallium Ga 68-DOTA… Proton Cranio-spinal Irradiation for Leptomeningeal Metastasis NCT05746754NA2 sites📍 Aarhus📍 Aalborg University of Aarhus · Tests: CSI Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease NCT07415018NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: MRI Scan, VUEWAY, Gadavist Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001 NCT07264569Phase 1, Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: BioTTT001 injection Natural History Study of Patients With Neurofibromatosis Type 2 NCT00598351n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… Evaluation of the CONVIVO System NCT05139277NA1 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: CONVIVO system, Conventional histologic evaluation 177Lu-DOTATATE for Recurrent Meningioma NCT06326190Phase 219 sites📍 Innsbruck📍 Vienna📍 Lyon European Organisation for Research and Treatment of Cancer … · Tests: Local standard of Care, 177Lu-DOTATATE Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults NCT04501705NA1 site📍 Beijing Beijing Sanbo Brain Hospital · Tests: Apatinib Mesylate Regorafenib for Recurrent Meningioma (MIRAGE Trial) NCT06275919Phase 220 sites📍 Meldola📍 Messina📍 Bagno a Ripoli Istituto Oncologico Veneto IRCCS · Tests: Regorafenib 40 MG Oral Tablet, Local Standard of Care Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis NCT07348965NA1 site📍 Guangzhou Guangzhou University of Traditional Chinese Medicine · Tests: Furmonertinib 320mg qod po, Furmonertinib 160mg qd po Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment NCT06955169Phase 217 sites📍 Irvine📍 La Jolla📍 New Haven RTOG Foundation, Inc. · Tests: [177Lu]Lu-DOTATATE, Standard of Care treatments Robot-Assisted Neurovascular Intervention NCT06752096NA1 site📍 Seoul Navigantis Inc. · Tests: cerebral angiography, arterial embolization, thrombectomy, Cerebral angiogram using robotic device, Meningioma emboliza… HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) NCT06930846NA1 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: HOBSCOTCH-CA Abemaciclib in Newly Diagnosed Meningioma Patients NCT05940493Phase 21 site📍 Phoenix Nader Sanai · Tests: Abemaciclib, Placebo Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE NCT06377371Phase 41 site📍 New York Weill Medical College of Cornell University · Tests: Brain Imaging with [Cu64]DOTATATE, Radio-guided Surgery With Neoprobe Utilization Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) NCT04427384n/a54 sites📍 Phoenix📍 Little Rock📍 Castro Valley GT Medical Technologies, Inc. · Tests: GammaTile Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial NCT06500481Phase 358 sites📍 Phoenix📍 Little Rock📍 Encinitas NRG Oncology · Tests: Biospecimen Collection, Computed Tomography, Involved-Field Radiation Therapy, Lumbar Puncture, Magnetic Resonance Imag… Predictive Factors for Survival in Aggressive Meningiomas NCT05793034NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Biological biomarker assessment Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial NCT06126588Phase 22 sites📍 Vandœuvre-lès-Nancy📍 Vandœuvre-lès-Nancy Central Hospital, Nancy, France · Tests: Everolimus Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema NCT06710249Phase 21 site📍 Lund Peter Siesjö · Tests: Salovum/SPC flakes Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC NCT06663306Phase 11 site📍 Shanghai Shanghai Chest Hospital · Tests: Pemetrexed, Bevacizumab CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease NCT05257967NA1 site📍 Vancouver British Columbia Cancer Agency · Tests: Lumbar puncture and Phlebotomy Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients NCT05990556NA1 site📍 Guangzhou First Affiliated Hospital, Sun Yat-Sen University · Tests: interventional procedure to block bilateral meningeal blood supply Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases NCT07304739Phase 23 sites📍 Cangzhou📍 Tianjin📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Furmonertinib, Intrathecal chemotherapy, Stereotactic radiotherapy Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer NCT06304441NA1 site📍 Huizhou Guangzhou Medical University · Tests: Osimertinib, Pemetrexed UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions NCT04343157Phase 21 site📍 San Diego Jona Hattangadi-Gluth · Tests: Cognitive Sparing Brain Stereotactic Radiosurgery (SRS) Zorifertinib With Osimertinib for NSCLC With Meningeal Progression NCT07361705Phase 15 sites📍 Beijing📍 Shengyang📍 Guangzhou Alpha Biopharma (Jiangsu) Co., Ltd. · Tests: Zorifertinib and Osimertinib Combination Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy